Citi Appointed as Depositary Bank for Valneva SE's ADR Programme
Citi, acting through Citibank N.A., has been appointed by Valneva SE ("Valneva"), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, to act as depositary bank for its American Depositary Receipt ("ADR") programme.
Valneva's American Depositary Shares ("ADS") trade on the Nasdaq Global Select Market under the symbol "VALN". Each ADS represents two ordinary shares of the company. Valneva's underlying ordinary shares are listed and trade on Euronext Paris under the symbol "VLA".
David Lawrence, Acting CFO of Valneva, said: "We are pleased to be working with Citi as part of our team supporting our newly acquired Nasdaq listing."